Cargando…
Risk Factors of Hypersensitivity to Carboplatin in Patients with Gynecologic Malignancies
We evaluated the prevalence of and risk factors for hypersensitivity reactions related to carboplatin, which is commonly used to treat gynecological malignancies. All women with pathologically documented ovarian, fallopian tube, or primary peritoneal cancer treated with carboplatin alone or a carbop...
Autores principales: | Tai, Yu-Hsiao, Tai, Yi-Jou, Hsu, Heng-Cheng, Lee, Shu-Ping, Chen, Yun-Yuan, Chiang, Ying-Cheng, Chen, Yu-Li, Chen, Chi-An, Cheng, Wen-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681487/ https://www.ncbi.nlm.nih.gov/pubmed/29163180 http://dx.doi.org/10.3389/fphar.2017.00800 |
Ejemplares similares
-
Bevacizumab Dose Affects the Severity of Adverse Events in Gynecologic Malignancies
por: Lee, Shu-Ping, et al.
Publicado: (2019) -
Hypersensitivity to Carboplatin in Children with Malignancy
por: Ruggiero, Antonio, et al.
Publicado: (2017) -
Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions
por: Ruggiero, Antonio, et al.
Publicado: (2017) -
Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients
por: Lu, Hsiao-Yun, et al.
Publicado: (2020) -
Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: A population‐based analysis
por: Lai, Yen‐Ling, et al.
Publicado: (2021)